Guanhao Biotech's application for a non-public share issuance under the simplified procedure has had its review status changed to submitted for registration. The company plans to issue no more than 9.5401 million shares to specific investors, raising a total of 97.5 million yuan. The funds will be used for the industrialization project of biological dura mater repair materials, supplementing working capital, and repaying bank loans. The sponsor is Wanlian Securities.
Guanhao Biotech Co LtdNon-public share issuance approved for registration, raising funds for projects and working capital.
